RE-BVS – Piemonte Repository

Sfoglia per AUTORE
PASSALACQUA G
Collezione AOU Città della Salute di Torino

Items : 7

Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus. in The journal of allergy and clinical immunology. In practice / J Allergy Clin Immunol Pract. 2023 Dec;11(12):3629-3637. doi: 10.1016/j.jaip.2023.07.041. Epub 2023

2023
AO Cuneo
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Yacoub MR; Yang B; Varricchi G; Vianello A; Solidoro P; Senna G; Scichilone N; Scioscia G; Ridolo E; Rolo J; Ricciardi L; Pini L; Puggioni F; Passalacqua G; Patella V; Pelaia G; Parente R; Parazzini EM; Macchia L; Milanese M; Montagni M; Latorre M; Lombardi C; Foschino MP; Ferri S; Fierro V; Facciolongo NC; Di Proietto MC; Crivellaro M; et alii...

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life. in The World Allergy Organization journal / World Allergy Organ J. 2021 Jan 27;14(2):100509. doi: 10.1016/j.waojou.2021.100509. eCollection 2021

2021
AO Ordine Mauriziano
AOU Città della Salute di Torino

Canevari RF; Bucca C; Manfredi A; Lombardi C; Milanese M; Senna G; Paggiaro P; Canonica GW; Menzella F; Heffler E; Rolla G; Caminati M; Povero M; Pradelli L; Brussino L; Bagnasco D; Passalacqua G;

The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life. in Allergy / Allergy. 2020 Jun;75(6):1460-1463. doi: 10.1111/all.14135. Epub 2020 Feb 23.

2020
AO Ordine Mauriziano
AOU Città della Salute di Torino

Senna G; Testino E; Passalacqua G; Rolla G; Riccio AM; Milanese M; Paoletti G; Menzella F; Heffler E; Lombardi C; Guida G; De Ferrari L; Caruso C; D'Amato M; Canonica GW; Caminati M; Bucca C; Brussino L; Bonavia M; Massolo A; Bagnasco D;

One year of mepolizumab. Efficacy and safety in real-life in Italy. in Pulmonary pharmacology & therapeutics / Pulm Pharmacol Ther. 2019 Oct;58:101836. doi: 10.1016/j.pupt.2019.101836. Epub 2019 Aug 29.

2019
AO Ordine Mauriziano
AOU Città della Salute di Torino

Riccio AM; Bonavia M; Senna G; Guida G; Caruso C; Manfredi A; Testino E; Paoletti G; Heffler E; Bucca C; Lombardi C; Rolla G; Milanese M; Caminati M; Menzella F; Bagnasco D; Canonica GW; Passalacqua G;

The North-Western Italian experience with anti IL-5 therapy amd comparison with regulatory trials. in The World Allergy Organization journal / World Allergy Organ J. 2018 Dec 6;11(1):34. doi: 10.1186/s40413-018-0210-7. eCollection 2018.

2018
AO Ordine Mauriziano
AOU Città della Salute di Torino

Bagnasco D; Passalacqua G; Heffler E; Canonica GW; Bucca C; Lombardi C; Bagnasco D; Rolla G; Milanese M; Milanese M; Rolla G; Lombardi C; Bucca C; Heffler E; Canonica GW; Passalacqua G;

Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). in Clinical and translational allergy / Clin Transl Allergy. 2017 Feb 20;7:5. doi: 10.1186/s13601-016-0135-6. eCollection 2017.

2017
AOU Città della Salute di Torino

Bousquet J; Farrell J; Crooks G; Hellings P; Bel EH; Bewick M; Chavannes NH; de Sousa JC; Cruz AA; Haahtela T; Joos G; Khaltaev N; Malva J; Muraro A; Nogues M; Palkonen S; Pedersen S; Robalo-Cordeiro C; Samolinski B; Strandberg T; Valiulis A; Yorgancioglu A; Zuberbier T; Bedbrook A; Aberer W; Adachi M; Agusti A; Akdis CA; Akdis M; et alii...

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). in Clinical and translational allergy / Clin Transl Allergy. 2016 Jul 29;6:29. doi: 10.1186/s13601-016-0116-9. eCollection 2016.

2016
AOU Città della Salute di Torino